†Jan Bieschke and Ehud Cohen contributed equally to this work.
Article
You have full text access to this OnlineOpen article
A kinetic assessment of the C. elegans amyloid disaggregation activity enables uncoupling of disassembly and proteolysis
Article first published online: 21 AUG 2009
DOI: 10.1002/pro.234
Copyright © 2009 The Protein Society
Additional Information
How to Cite
Bieschke, J., Cohen, E., Murray, A., Dillin, A. and Kelly, J. W. (2009), A kinetic assessment of the C. elegans amyloid disaggregation activity enables uncoupling of disassembly and proteolysis. Protein Science, 18: 2231–2241. doi: 10.1002/pro.234
Publication History
- Issue published online: 23 OCT 2009
- Article first published online: 21 AUG 2009
- Accepted manuscript online: 21 AUG 2009 12:00AM EST
- Manuscript Accepted: 13 AUG 2009
- Manuscript Received: 27 MAY 2009
Funded by
- NGFNplus. Grant Number: 01GS08132
- NIH. Grant Number: AG031097
- The Bundy Foundation
- Helmholz Gemeinschaft
- Skaggs Institute for Chemical Biology
- Lita Annenberg Hazen Foundation
References
- 1( 1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8: 101–106.
- 2( 2003) Protein folding and misfolding. Nature 426: 884–890.
- 3( 2004) Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6: 1054–1061.
- 4, , , , , , , ( 2005) The biological and chemical basis for tissue-selective amyloid disease. Cell 121: 73–85.
- 5, , , , , , , , , ( 1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90: 549–558.
- 6( 2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361: 1642–1644.
- 7( 1998) The prion diseases. Brain Pathol 8: 499–513.
- 8, ( 2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545–555.
- 9, , , ( 2008) Adapting proteostasis for disease intervention. Science 319: 916–919.
- 10, ( 2008) The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci 9: 759–767.
- 11, , ( 2007) The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv Exp Med Biol 594: 167–189.
- 12, , , ( 2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci USA 99: 10417–10422.
- 13, , ( 2002) Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298: 830–834.
- 14, ( 1994) Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 7: 283–286.
- 15( 2005) The plasticity of aging: insights from long-lived mutants. Cell 120: 449–460.
- 16, , , , , , , ( 2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182–187.
- 17, , , , , , , ( 2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 105: 3438–3442.
- 18, , , , , , , , , ( 2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci USA 105: 13987–13992.
- 19, , ( 2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300: 1142–1145.
- 20, ( 2004) Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell 15: 657–664.
- 21( 1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92: 9368–9372.
- 22, , , , ( 2006) Opposing activities protect against age-onset proteotoxicity. Science 313: 1604–1610.
- 23, ( 2006) Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J 273: 1331–1349.
- 24, ( 2004) Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304: 1793–1797.
- 25, , , ( 1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 94: 4109–4112.
- 26, , , , , , , , , , , , , , , , , , , , , , , , ( 1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173–177.
- 27, , , , , , , ( 2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087–1093.
- 28, ( 2006) The kinetics of nucleated polymerizations at high concentrations: amyloid fibril formation near and above the “supercritical concentration”. Biophys J 91: 122–132.
- 29, , , , ( 2005) Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44: 4977–4983.
- 30( 1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309: 274–284.
- 31, , ( 2005) The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol 149: 30–37.
- 32, , , , , ( 2007) Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1–40) amyloid fibrils. J Mol Biol 373: 1321–1333.
- 33, ( 2006) Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol Cell 23: 425–438.
- 34, , , ( 1994) Protein disaggregation mediated by heat-shock protein Hsp104. Nature 372: 475–478.
- 35, ( 1998) Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94: 73–82.

1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
